Ergoteles’s Zimmer Biomet ZBH Stock Holding History

Ergoteles’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,500	Closed	-$452K	–	1587
2023 Q1	$452K	Sell	3,500 -465	-12%	-$58.4K	0.02%	770
2022 Q4	$506K	Buy	+3,965	New	+$460K	0.02%	694
2022 Q3	–	Sell	-2,709	Closed	-$285K	–	2052
2022 Q2	$285K	Buy	+2,709	New	+$321K	0.01%	1129
2021 Q4	–	Sell	-1,668	Closed	-$237K	–	1648
2021 Q3	$237K	Buy	+1,668	New	+$245K	0.01%	906
2021 Q1	–	Sell	-3,079	Closed	-$461K	–	1102
2020 Q4	$461K	Buy	+3,079	New	+$435K	0.02%	469

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Ergoteles's ZBH Position: Q2 2023 in Review

Ergoteles sold out of Zimmer Biomet (ZBH) in Q2 2023, closing a stake of 3,500 shares — an estimated $452K sold.

Ergoteles first reported a position in ZBH in Q4 2020 and held it in 5 quarters. The position peaked at $506K in Q4 2022. 1,031 funds tracked by Wall St. Rank hold ZBH as of Q2 2023.

Ergoteles reported no remaining Zimmer Biomet position as of Q2 2023 after selling out during the quarter.
Ergoteles sold 3,500 Zimmer Biomet shares in Q2 2023, an estimated $452K.
Ergoteles first reported a position in Zimmer Biomet in Q4 2020 and held it in 5 quarters.
Ergoteles's Zimmer Biomet position peaked at $506K in Q4 2022.
1,031 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.